1.Frequency and molecular epidemiology of Panton-Valentine leukocidin gene in Staphylococcus aureus colonising HIV-infected patients
Zaini Mohd-Zain ; Siti Farah Alwani Mohd-Nawi ; Ariza Adnan ; Suresh Kumar
The Malaysian Journal of Pathology 2017;39(2):115-122
Background: HIV-infected patients pose a high risk of contracting skin and soft tissue infections
caused by Staphylococcus aureus. Those who are colonized with methicillin-resistant S. aureus
(MRSA) that carry Panton-Valentine leukocidin (PVL) are predisposed to severe infections that
could lead to necrotic skin infections. However the association of S. aureus specifically methicillin
sensitive S. aureus carrying PVL gene in HIV patients has not been widely reported. Here, we
study the prevalence and the molecular epidemiology of PVL-producing S. aureus in HIV-infected
patients. Methods: Swabs from four body sites of 129 HIV-infected patients were cultured for
S. aureus and identified by standard microbiological procedures. The isolates were subjected to
antimicrobial susceptibility testing by disk diffusion against penicillin, erythromycin, clindamycin,
and cotrimoxazole. PCR was used to detect the PVL gene and genetic relationship between the
isolates was determined by using pulse field gel electrophoresis. Results: A total of 51 isolates of
S. aureus were obtained from 40 (31%) of the patients. The majority (43.1%) of the isolates were
obtained from the anterior nares. Thirteen (25.5%) of all the isolates were resistant to more than
one category of antibiotics, with one isolate identified as MRSA. Thirty-eight (74.5%) isolates
(including the MRSA isolate) carried PVL gene where the majority (44.7%) of these isolates were
from the anterior nares. A dendogram revealed that the isolates were genetically diverse with 37
distinct pulsotypes clustered in 11 groups. Conclusion: S. aureus obtained from multiple sites of
the HIV patients were genetically diverse without any clonality observed.
2.Community-acquired bacteremia in Paediatrics:Epidemiology, aetiology and patterns of antimicrobial resistance in a tertiary care centre, Malaysia
Nor Azizah Abu ; Fadzilah Mohd Nor ; Mariam Mohamad ; Anis Siham Zainal Abidin ; Ariza Adnan ; Noor Shafina Mohd Nor ; A Anita Kaur
The Medical Journal of Malaysia 2016;71(3):117-121
Introduction: bacteremia continues to be one of the major
causes of morbidity and mortality despite the existence of
numerous antimicrobial agents. this study aimed to provide
a Malaysian perspective on paediatric community-acquired
bacteraemia based on the documentation of epidemiology
and antimicrobial profile of the isolated pathogens.
Method: A retrospective study was conducted by analysing
clinical details, blood cultures and antimicrobial
susceptibility testing results in children between the ages of
0 to 13 years old, who were admitted to selayang Hospital
over an 11-year period from 2001 until 2011. there were 222
bacteraemia cases and the median age was 11.7 months.
the highest number (39%) of bacteraemia cases occurred
between ages one month to one year. the three most
commonly isolated aetiological agents were
Staphylococcus aureus (17.1%), nontyphoidal Salmonella
(16.2%), and Streptococcus pneumoniae (12.6%). Almost 8%
of the Staphylococcus aureus isolates were methicillin
resistant, while nontyphoidal Salmonella (Nts) isolates
demonstrated 18.4%, 10.5% and 2.6% resistance towards
ampicillin, trimethoprim-sulfamethoxazole and ciprofloxacin
respectively. All Nts isolates were sensitive to ceftriaxone.
Streptococcus pneumoniae isolates showed 17.9%
resistance to penicillin. skin and soft tissue infections as
well as lower respiratory tract infections (63.2%) were the
main foci of infections in Staphylococcus aureus
bacteraemia. Acute gastroenteritis (80.0%) and pneumonia
(60.8%) were the main presentations of Nts and
Streptococcus pneumoniae bacteraemia respectively.
Overall mortality rate was 8.1%.
Conclusion: Knowledge on the local epidemiology and
antibiotic resistance pattern serves as a significant platform
in improving the empiric antibiotic therapy for patients with
community acquired bacteraemia.
Anti-Infective Agents
;
Bacteremia